Who Owns Opus Genetics Stock?
NASDAQ: IRDHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Nov 20, 4:00 PM ET · Delayed 15 min
Ownership breakdown
- Held by institutions
- 80.09%
- Held by insiders
- 10.44%
- Institutional holders
- 146
- Institutions 80.1%
- Insiders 10.4%
- Public and other 9.5%
Who owns Opus Genetics stock?
Institutional investors own about 80.1% of Opus Genetics's shares, spread across 146 institutions that file 13F reports. That level of institutional ownership is high, typical of large, widely followed companies. Insiders, including executives, directors and large founding shareholders, hold 10.44% of IRD.
The largest institutional holders are Perceptive Advisors Llc (9.31%), Caligan Partners, LP (6.17%) and Cormorant Asset Management, LP (5.69%). Together, the top 10 institutions control 50.3% of shares outstanding. In their latest filings, 8 of the top 10 institutions increased their IRD positions and 1 reduced them.
Summary generated from market data by MetaCap's automated system. Methodology
Top institutional holders of IRD
| Institution | Shares | % Held | Change |
|---|---|---|---|
| Perceptive Advisors Llc | 9.00M | 9.31% | +100.0% |
| Caligan Partners, LP | 5.96M | 6.17% | -1.9% |
| Cormorant Asset Management, LP | 5.50M | 5.69% | +100.0% |
| Blackrock Inc. | 5.24M | 5.42% | +68.0% |
| Nantahala Capital Management, LLC | 4.57M | 4.73% | +49.3% |
| Boxer Capital Management, LLC | 4.53M | 4.69% | +61.0% |
| Balyasny Asset Management LP | 3.73M | 3.86% | +20.8% |
| Bios Capital Management, LP | 3.68M | 3.81% | 0.0% |
| Vanguard Capital Management LLC | 3.27M | 3.39% | +10.6% |
| Marshall Wace LLP | 3.16M | 3.27% | +62.5% |
% held is the share of total shares outstanding. Change is the percentage change in the position since the holder's previous 13F filing.
Top mutual fund and ETF holders of IRD
| Fund | Shares | % Held |
|---|---|---|
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | 2.24M | 2.32% |
| iShares Trust-iShares Russell 2000 ETF | 1.79M | 1.85% |
| VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund | 652.28K | 0.67% |
| iShares Trust-iShares Russell 2000 Growth ETF | 643.91K | 0.67% |
| Fidelity Salem Street Trust-Fidelity Small Cap Index Fund | 583.65K | 0.60% |
| Fidelity Concord Street Trust-Fidelity Extended Market Index Fund | 358.02K | 0.37% |
| VANGUARD SCOTTSDALE FUNDS-Vanguard Russell 2000 Index Fund | 307.75K | 0.32% |
| iShares Trust-iShares Micro-Cap ETF | 219.14K | 0.23% |
| Fidelity Concord Street Trust-Fidelity Total Market Index Fund | 160.56K | 0.17% |
| SCHWAB CAPITAL TRUST-Schwab Small-Cap Index Fund | 130.04K | 0.13% |
Frequently asked questions
Who is the largest shareholder of Opus Genetics?
Perceptive Advisors Llc is the largest institutional shareholder of IRD, owning 9.31% of shares outstanding (9.00M shares) as of its latest 13F filing.
What percentage of Opus Genetics is owned by institutions?
Institutions own about 80.1% of IRD shares and 89.4% of the public float.
How much of Opus Genetics do insiders own?
Insiders, such as officers and directors, own about 10.44% of IRD shares outstanding.
Where does institutional ownership data come from?
Investment managers with more than $100 million in US equities must file Form 13F with the SEC within 45 days of each quarter-end. Holdings are therefore up to about 4.5 months old when published.